Imagine you are developing antibodies—drugs precisely aimed at a target, for example a viral protein or onco-marker. You test a series of antibodies and find that some work, while others do not.
Machine learning and artificial intelligence are set to play a significant role in the future of drug development. Recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback